Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regenxbio (RGNX) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Regenxbio (RGNX) over the last 12 years, with Q3 2025 value amounting to $4.3 million.

  • Regenxbio's Other Non-Current Assets rose 11024.63% to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year increase of 11024.63%. This contributed to the annual value of $4.0 million for FY2024, which is 1678.8% down from last year.
  • As of Q3 2025, Regenxbio's Other Non-Current Assets stood at $4.3 million, which was up 11024.63% from $2.0 million recorded in Q2 2025.
  • Over the past 5 years, Regenxbio's Other Non-Current Assets peaked at $4.8 million during Q4 2023, and registered a low of $1.3 million during Q1 2021.
  • Over the past 5 years, Regenxbio's median Other Non-Current Assets value was $2.0 million (recorded in 2021), while the average stood at $2.4 million.
  • Per our database at Business Quant, Regenxbio's Other Non-Current Assets surged by 13679.8% in 2023 and then tumbled by 1678.8% in 2024.
  • Over the past 5 years, Regenxbio's Other Non-Current Assets (Quarter) stood at $2.0 million in 2021, then changed by 0.0% to $2.0 million in 2022, then skyrocketed by 136.8% to $4.8 million in 2023, then fell by 16.79% to $4.0 million in 2024, then increased by 6.7% to $4.3 million in 2025.
  • Its last three reported values are $4.3 million in Q3 2025, $2.0 million for Q2 2025, and $3.0 million during Q1 2025.